(Q21032520)

30 June 2019

meta-analysis

0 references

title

Artesunate versus quinine for treating severe malaria (English)

1 reference

30 June 2019

0 references

0 references

2

Sarah Donegan

Sarah

Donegan

1 reference

27 July 2022

3

Rachel Isba

Rachel

Isba

1 reference

27 July 2022

David G Lalloo

4

David G

Lalloo

1 reference

27 July 2022

1

David

Sinclair

David Sinclair

2 references

30 June 2019

27 July 2022

13 June 2012

1 reference

30 June 2019

Cochrane Database of Systematic Reviews

published in

1 reference

30 June 2019

issue

6

1 reference

30 June 2019

page(s)

CD005967

1 reference

30 June 2019

Comparison of artemisinin suppositories, intramuscular artesunate and intravenous quinine for the treatment of severe childhood malaria

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005967.PUB4

Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005967.PUB4

Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005967.PUB4

Comparison of artesunate and quinine in the treatment of Sudanese children with severe Plasmodium falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005967.PUB4

Comparison of artemisinin suppositories with intravenous artesunate and intravenous quinine in the treatment of cerebral malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005967.PUB4

Randomized comparison of artesunate and quinine in the treatment of severe falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005967.PUB4

Efficacy of rectal artesunate compared with parenteral quinine in initial treatment of moderately severe malaria in African children and adults: a randomised study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005967.PUB4

Randomized comparison of quinine-clindamycin versus artesunate in the treatment of falciparum malaria in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005967.PUB4

Artemisinin antimalarials in pregnancy: a prospective treatment study of 539 episodes of multidrug-resistant Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005967.PUB4

Randomized control trial of quinine and artesunate in complicated malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005967.PUB4

A comparison of artesunate alone with combined artesunate and quinine in the parenteral treatment of acute falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005967.PUB4

Activities of artesunate and primaquine against asexual- and sexual-stage parasites in falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005967.PUB4

Artesunate combinations for treatment of malaria: meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005967.PUB4

Intramuscular arteether for treating severe malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005967.PUB4

Antimalarial drug toxicity: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005967.PUB4

A meta-analysis using individual patient data of trials comparing artemether with quinine in the treatment of severe falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005967.PUB4

Acquired immunity to malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005967.PUB4

Behavioral and neural toxicity of the artemisinin antimalarial, arteether, but not artesunate and artelinate, in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005967.PUB4

Comparative pharmacokinetics of intramuscular artesunate and artemether in patients with severe falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005967.PUB4

Pharmacokinetics and bioavailability of oral and intramuscular artemether

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005967.PUB4

Artemisinin derivatives versus quinine for cerebral malaria in African children: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005967.PUB4

High first dose quinine regimen for treating severe malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005967.PUB4

Dose-finding and efficacy study for i.m. artemotil (beta-arteether) and comparison with i.m. artemether in acute uncomplicated P. falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005967.PUB4

Cost-effectiveness of artesunate for the treatment of severe malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005967.PUB4

Cost-effectiveness of parenteral artesunate for treating children with severe malaria in sub-Saharan Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005967.PUB4

Artemisinin derivatives for treating severe malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005967.PUB4

Population pharmacokinetics of artemether and dihydroartemisinin following single intramuscular dosing of artemether in African children with severe falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005967.PUB4

The disposition of intramuscular artemether in children with cerebral malaria; a preliminary study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005967.PUB4

Intramuscular bioavailability and clinical efficacy of artesunate in gabonese children with severe malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005967.PUB4

Assessment of the neurotoxicity of oral dihydroartemisinin in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005967.PUB4

Plasmodium falciparum: in vitro studies of the pharmacodynamic properties of drugs used for the treatment of severe malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005967.PUB4

Audiometric changes associated with the treatment of uncomplicated falciparum malaria with co-artemether

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005967.PUB4

Loading dose of quinine in African children with cerebral malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005967.PUB4

Severe Hypoglycemia and Hyperinsulinemia in Falciparum Malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005967.PUB4

Epidemiology of drug-resistant malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005967.PUB4

Safety of artemisinin and its derivatives. A review of published and unpublished clinical trials

21 January 2018

1 reference

12 December 2020

Studies of the neurotoxicity of oral artemisinin derivatives in mice.

1 reference

12 December 2020

Clinical and neurophysiological study of the effects of multiple doses of artemisinin on brain-stem function in Vietnamese patients

1 reference

12 December 2020

Randomized trial of artesunate and mefloquine in comparison with quinine sulfate to treat P. falciparum malaria pregnant women

1 reference

12 December 2020

Descriptive study on the efficacy and safety of artesunate suppository in combination with other antimalarials in the treatment of severe malaria in Sudan.

1 reference

12 December 2020

Clinical experience with intravenous quinine, intramuscular artemether and intravenous artesunate for the treatment of severe malaria in Thailand.

1 reference

12 December 2020

Comparison of combinations of parenteral artemisinin derivatives plus oral mefloquine with intravenous quinine plus oral tetracycline for treating cerebral malaria

1 reference

12 December 2020

Pharmacokinetic investigation on the therapeutic potential of artemotil (beta-arteether) in Thai patients with severe Plasmodium falciparum malaria

1 reference

12 December 2020

Artemisinin-based combination treatment of falciparum malaria.

1 reference

12 December 2020

Randomized controlled trial of artesunate or artemether in Vietnamese adults with severe falciparum malaria

1 reference

12 December 2020

Quinine Loading Dose in Cerebral Malaria *

1 reference

12 December 2020

Fatal neurotoxicity of arteether and artemether

1 reference

12 December 2020

Detecting skewness from summary information

1 reference

12 December 2020

Predictors of a fatal outcome following childhood cerebral malaria.

2 references

12 December 2020

https://api.crossref.org/works/10.1002%2F14651858.CD005967.PUB4

7 January 2021

inferred from DOI database lookup

Assessment of the neurotoxicity of parenteral artemisinin derivatives in mice

1 reference

12 December 2020

10.1002/14651858.CD005967.PUB4

Identifiers

DOI

1 reference

30 June 2019

OpenCitations bibliographic resource ID

2323059

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

30 June 2019

PubMed ID

22696354

1 reference

30 June 2019